BNP Paribas Knock-Out 4AB/ DE000PF326H1 /
5/6/2024 2:20:56 PM | Chg.+0.050 | Bid2:40:43 PM | Ask2:40:43 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
6.810EUR | +0.74% | 6.810 Bid Size: 13,000 |
6.860 Ask Size: 13,000 |
ABBVIE INC. D... | 91.391 - | 12/31/2078 | Call |
GlobeNewswire
2:00 PM
Pacific Software Inc. Announces a Landmark Asset Acquisition from Dreamaderm Inc.
GlobeNewswire
5/2
Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer a...
GlobeNewswire
5/1
CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
GlobeNewswire
4/30
CEREVEL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Cerevel Therapeutics Holdings,...
GlobeNewswire
4/30
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentratio...
GlobeNewswire
4/25
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024
GlobeNewswire
4/25
Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes ...
GlobeNewswire
4/24
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeti...
GlobeNewswire
4/23
Leaders from Fortune 100 Best Companies to Work For To Share Insights at For All Summit May 7-9
GlobeNewswire
4/22
TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - ALPN, LABP, SWAV, FUS...
GlobeNewswire
4/19
NurExone Presenting on Revolutionary Spinal Cord Injury Therapy at European Conference on Exosomes a...
GlobeNewswire
4/19
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable...
GlobeNewswire
4/18
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial fo...
GlobeNewswire
4/16
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara®...
GlobeNewswire
4/16
OSE Immunotherapeutics’ Global License to Develop a Novel Monoclonal Antibody for the Treatment of C...
GlobeNewswire
4/16
Nxera Pharma Notes Successful Development Progress of Partnered Schizophrenia Candidate NBI-1117568
GlobeNewswire
4/15
Ocular Therapeutix™ Executive Chairman Pravin U. Dugel, MD Becomes President and CEO Antony Mattessi...
Newsfile Corp
4/12
Allergan Aesthetics and University Lab Partners Announce the Golden Ticket Pitch Competition to Acce...